Showing results (31-40 of 497) with videos related to
Sort By:
Pageof 50
Immunology|August 1, 1978
The differentiation of murine thymocytes in vivo and in vitroT E Mandel, M M KennedyTransplantation|April 27, 1994
A comparison of corneal, pancreas, and skin grafts in mice. A study of the determinants of tissue immunogenicityR H Guymer, T E MandelTransplantation|January 1, 1993
Urocanic acid as an immunosuppressant in allotransplantation in miceR H Guymer, T E MandelAustralian and New Zealand Journal of Ophthalmology|February 1, 1990
The prevention of diabetic retinal and renal basement membrane thickening in mice by islet cell allograftsM C Gillies, T E MandelMetabolism: Clinical and Experimental|December 1, 1990
The evolution of function and response to arginine challenge and pregnancy of portally and systemically placed islet cell grafts in streptozotocin diabetic miceM C Gillies, T E MandelHormone and Metabolic Research. Supplement Series|January 1, 1990
Fetal pancreas transplantation in non-obese diabetic (NOD) mice. A comparison of iso-, allo- and xenograftsT E Mandel, M Koulmanda, A BaceljTransplantation|May 1, 1989
An increase in the survival of murine H-2-mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies, and a further increase with the addition of cyclosporineK Burkhardt, B Charlton, T E MandelDiabetes|July 1, 1988
Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamideB Charlton, A Bacelj, T E MandelXenotransplantation|December 16, 1998
Cyclophosphamide, but not CTLA4Ig, prolongs survival of fetal pig islet grafts in anti-T cell monoclonal antibody-treated NOD miceM Koulmanda, J Kovarik, T E MandelDiabetes|November 1, 1989
Prevention of cyclophosphamide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi miceA Bacelj, B Charlton, T E MandelPageof 50